Nathalie Debroas

Nathalie Debroas is a seasoned professional with extensive experience in the pharmaceutical and medical sectors. Currently serving as Responsable Grands Comptes at Provepharm since August 2023, Nathalie has held various roles including Account Manager Key Account at Medical Developments International (MDI) since September 2021, focusing on the development of Penthrox. Previous positions include Hospital Representative at BIOGARAN, where Nathalie launched two biosimilar medications, and Déléguée Hospitalière at Aguettant Ltd, concentrating on the development of APOKINON among neurologists. Nathalie's career began at Celltech Pharma S.A., where notable achievements included the launch of multiple products and vaccines. Educational qualifications include a DEUG in Histoire de l'Art et Archéologie from the faculté d'Aix en Provence and a Diplôme National de la Visite Médicale from IFOPS.